Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/3/2025

Alternative Antidepressants for GAD After Failed SSRI Treatment

First-Line Alternatives After SSRI Failure

  • Venlafaxine has shown superior efficacy compared to fluoxetine for treating anxiety symptoms and is a recommended option for patients who have failed SSRI treatment 1, 2
  • Mirtazapine has a faster onset of action than SSRIs and may be beneficial when rapid symptom relief is needed, though response rates eventually become similar after 4 weeks 3, 4
  • Bupropion can be considered as an augmentation strategy when switching medications isn't effective, particularly when added to an existing SSRI 5, 6

Evidence for Treatment-Resistant GAD

  • The STAR*D study showed that approximately 1 in 4 patients became symptom-free after switching medications, with no significant differences in efficacy between bupropion, sertraline, and venlafaxine 2, 7
  • When switching from one medication class to another (e.g., from SSRIs to SNRIs), the likelihood of response increases compared to switching within the same class 7, 6

Augmentation Strategies

  • Adding bupropion to an existing SSRI/SNRI can decrease depression severity more than augmentation with buspirone 6
  • Combination therapy approaches may be beneficial for patients with partial response to monotherapy 6

Special Considerations

  • For GAD with comorbid insomnia, mirtazapine may be particularly helpful due to its sedating properties 3, 4